Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ

Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ

Daniel Duprez1, Keith Ferdinand2, Das Purkayastha3, Rita Samuel3, Richard Wright41University of Minnesota, Minneapolis, MN, 2Atlanta Clinical Research Centers, Atlanta, GA, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, 4Pacific Heart Institute, Santa Monica, CA, USABackground: Stage 2 hyp...

Full description

Bibliographic Details
Main Authors: Duprez D, Ferdinand, Wright
Format: Article
Language:English
Published: Dove Medical Press 2011-11-01
Series:Vascular Health and Risk Management
Subjects:
Ambulatory blood pressure
ABP
ABPM
Combination therapy
Angiotensin receptor blocker
ARB
Antihypertensive Therapy
Online Access:https://www.dovepress.com/ambulatory-blood-pressure-response-to-triple-therapy-with-an-angiotens-peer-reviewed-article-VHRM

Internet

https://www.dovepress.com/ambulatory-blood-pressure-response-to-triple-therapy-with-an-angiotens-peer-reviewed-article-VHRM

Similar Items